BioPlus Acquisition (NASDAQ:BIOSU) Shares Down 0.2%

BioPlus Acquisition Corp. (NASDAQ:BIOSUGet Free Report)’s share price was down 0.2% during trading on Monday . The company traded as low as $10.81 and last traded at $10.81. Approximately 500 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 3,195 shares. The stock had previously closed at $10.83.

BioPlus Acquisition Trading Down 0.2 %

The company has a 50-day moving average price of $10.72 and a two-hundred day moving average price of $10.59.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of BIOSU. Susquehanna International Group LLP bought a new stake in BioPlus Acquisition during the fourth quarter worth about $105,000. State Street Corp bought a new stake in shares of BioPlus Acquisition in the 1st quarter worth approximately $184,000. Robinson Capital Management LLC boosted its stake in shares of BioPlus Acquisition by 55.2% in the 1st quarter. Robinson Capital Management LLC now owns 25,293 shares of the company’s stock valued at $252,000 after purchasing an additional 9,000 shares in the last quarter. Finally, Cubist Systematic Strategies LLC bought a new position in shares of BioPlus Acquisition during the 3rd quarter valued at $343,000.

About BioPlus Acquisition

(Get Free Report)

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Recommended Stories

Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with's FREE daily email newsletter.